[Pheochromocytomas and paragangliomas: implications of new insights for diagnosis and treatment].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 18389879)

Published in Ned Tijdschr Geneeskd on March 01, 2008

Authors

E P M van der Kleij-Corssmit1, B Havekes, A H J T Vriends, J C Jansen, J A Romijn

Author Affiliations

1: Leids Universitair Medisch Centrum, Postbus 9600, 2300 RC Leiden. e.p.m.vanderkleij-corssmit@lumc.nl

Articles by these authors

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet (1999) 3.41

How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol (2009) 2.49

Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus. Diabetologia (2007) 1.94

Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways. AIDS (2001) 1.81

Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Arterioscler Thromb Vasc Biol (2004) 1.79

Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism (1991) 1.68

The suprachiasmatic nucleus generates the diurnal changes in plasma leptin levels. Endocrinology (2001) 1.63

Quality of life is decreased in female patients treated for microprolactinoma. Eur J Endocrinol (2007) 1.52

[Cushing's syndrome. II. New forms of treatment]. Ned Tijdschr Geneeskd (2006) 1.47

Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab (2007) 1.47

Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol (1995) 1.46

Results from craniocaudal carotid body tumor resection: should it be the standard surgical approach? Eur J Vasc Endovasc Surg (2013) 1.45

Progression of acromegalic arthropathy despite long-term biochemical control: a prospective, radiological study. Eur J Endocrinol (2012) 1.43

Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass. J Clin Endocrinol Metab (2001) 1.43

Infusion of long-chain or medium-chain triglycerides inhibits peripheral glucose metabolism in men. JPEN J Parenter Enteral Nutr (1995) 1.42

Lipid profiles in middle-aged men and women after famine exposure during gestation: the Dutch Hunger Winter Families Study. Am J Clin Nutr (2009) 1.42

Blood flow velocity changes in migraine attacks--a transcranial Doppler study. Cephalalgia (1991) 1.42

[The abdominal compartment syndrome]. Ned Tijdschr Geneeskd (2005) 1.41

Anencephaly in the Netherlands: a remarkable decline. Lancet (1983) 1.41

[Increased frequency of icterus in parenterally fed patients after a change of lipid emulsion]. Ned Tijdschr Geneeskd (1999) 1.40

[Transsphenoidal resection of pituitary adenomas: long-term results from the Leiden University Medical Center]. Ned Tijdschr Geneeskd (2008) 1.40

[Acne vulgaris: endocrine aspects]. Ned Tijdschr Geneeskd (2006) 1.38

Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol (2013) 1.36

Cushing's syndrome complicated by multiple opportunistic infections. J Endocrinol Invest (1998) 1.35

Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab (2005) 1.35

PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update (2011) 1.35

Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer (2001) 1.32

Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol (1991) 1.29

Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans. Clin Exp Immunol (1997) 1.28

In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes (2001) 1.25

Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab (2005) 1.22

Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab (1990) 1.19

Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene. J Clin Endocrinol Metab (2007) 1.17

Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis. Clin Endocrinol (Oxf) (2004) 1.15

Confinement of PGL, an imprinted gene causing hereditary paragangliomas, to a 2-cM interval on 11q22-q23 and exclusion of DRD2 and NCAM as candidate genes. Eur J Hum Genet (1996) 1.14

Aortic stiffness is associated with cardiac function and cerebral small vessel disease in patients with type 1 diabetes mellitus: assessment by magnetic resonance imaging. Eur Radiol (2009) 1.14

Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab (2007) 1.13

The natural course of non-functioning pituitary macroadenomas. Eur J Endocrinol (2007) 1.12

Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab (2008) 1.12

Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1. Diabetes (2001) 1.10

The quantification of gluconeogenesis in healthy men by (2)H2O and [2-(13)C]glycerol yields different results: rates of gluconeogenesis in healthy men measured with (2)H2O are higher than those measured with [2-(13)C]glycerol. J Clin Endocrinol Metab (2001) 1.10

Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Endocrinology (2013) 1.08

Dietary fat content alters insulin-mediated glucose metabolism in healthy men. Am J Clin Nutr (2001) 1.07

Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice. Diabetologia (2005) 1.07

Increased basal glucose production in type 1 Gaucher's disease. J Clin Endocrinol Metab (1995) 1.05

Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas. J Clin Endocrinol Metab (2009) 1.05

Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer. Int J Cancer (2011) 1.03

Preterm birth and later insulin resistance: effects of birth weight and postnatal growth in a population based longitudinal study from birth into adult life. Diabetologia (2006) 1.01

Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis. J Clin Endocrinol Metab (2009) 1.01

Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma. J Clin Endocrinol Metab (2003) 1.00

The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells. Biochem Pharmacol (2010) 1.00

Octreotide long-acting repeatable and lanreotide Autogel are equally effective in controlling growth hormone secretion in acromegalic patients. Eur J Endocrinol (2004) 1.00

A variable degree of intrauterine and postnatal growth retardation in a family with a missense mutation in the insulin-like growth factor I receptor. J Clin Endocrinol Metab (2006) 0.99

Cerebrospinal fluid leakage during transsphenoidal surgery: postoperative external lumbar drainage reduces the risk for meningitis. Pituitary (2004) 0.98

Sustained activation of the mammalian target of rapamycin nutrient sensing pathway is associated with hepatic insulin resistance, but not with steatosis, in mice. Diabetologia (2006) 0.98

Management of carotid body tumors. Otolaryngol Clin North Am (2001) 0.98

Reversible coma due to intrathecal baclofen. Lancet (1986) 0.97

Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging. Q J Nucl Med Mol Imaging (2008) 0.97

Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas. Eur J Endocrinol (2005) 0.97

Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab (2006) 0.96

White adipose tissue: getting nervous. J Neuroendocrinol (2003) 0.96

Increased resting energy expenditure in human immunodeficiency virus-infected men. Metabolism (1990) 0.96

Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats. Diabetes (2001) 0.96

Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E. J Hepatol (2001) 0.96

HIV-associated adipose redistribution syndrome as a selective autonomic neuropathy. Lancet (2003) 0.96

Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients. Diabetologia (2007) 0.95

Disturbed subjective sleep characteristics in adult patients with long-standing type 1 diabetes mellitus. Diabetologia (2011) 0.95

Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial. Clin Endocrinol (Oxf) (2006) 0.95

Membrane reactor technology for C5/C6 hydroisomerization. Philos Trans A Math Phys Eng Sci (2005) 0.95

Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease. Am J Med (1997) 0.94

Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas. Endocr Relat Cancer (2009) 0.94

The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma. Thyroid (2006) 0.93

Biologic responses to IFN-alpha administration in humans. J Interferon Cytokine Res (2000) 0.93

Quality of life in treated adult craniopharyngioma patients. Eur J Endocrinol (2006) 0.92

First experiences with genetic counselling based on predictive DNA diagnosis in hereditary glomus tumours (paragangliomas). J Med Genet (1996) 0.92

Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study. J Clin Endocrinol Metab (2005) 0.92

Leptin deficiency per se dictates body composition and insulin action in ob/ob mice. J Neuroendocrinol (2008) 0.92

Review article: Regulation of glucose production with special attention to nonclassical regulatory mechanisms: a review. Metabolism (2001) 0.91

Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits. Fam Cancer (2010) 0.91

Gut-brain axis: regulation of glucose metabolism. J Neuroendocrinol (2006) 0.91

Dietary carbohydrate deprivation increases 24-hour nitrogen excretion without affecting postabsorptive hepatic or whole body protein metabolism in healthy men. J Clin Endocrinol Metab (2003) 0.91

Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab (2006) 0.90

Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients. Clin Endocrinol (Oxf) (2011) 0.90

Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration. Br J Pharmacol (2014) 0.90

Nitric oxide inhibits glycogen synthesis in isolated rat hepatocytes. Biochem J (1998) 0.90

Parenteral nutrition following intensive cytotoxic therapy: an exploratory study on the need for parenteral nutrition after various treatment approaches for haematological malignancies. Bone Marrow Transplant (1999) 0.89

The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. J Clin Endocrinol Metab (2012) 0.89

Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab (1994) 0.89

High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. Eur J Endocrinol (2011) 0.89

Effects of tumor necrosis factor on the hypothalamic-pituitary-testicular axis in healthy men. Metabolism (1993) 0.88

Mitochondrial diabetes and its lessons for common Type 2 diabetes. Biochem Soc Trans (2006) 0.88